FilingSEC EDGARS-3
BridgeBio Oncology Therapeutics Enters into $200 Million ATM Sales Agreement
· SEC accepted
StageAgreement Signed
Filing content
BridgeBio Oncology Therapeutics has entered into a sales agreement with Leerink Partners and Cantor Fitzgerald to sell up to $200 million of its common stock.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…